2017
DOI: 10.1039/c6qo00847j
|View full text |Cite
|
Sign up to set email alerts
|

Asperspiropene A, a novel fungal metabolite as an inhibitor of cancer-associated mutant isocitrate dehydrogenase 1

Abstract: In silico screening of an in-house natural product database and confirmatory bioassays led to the identification of asperspiropene A (1) as an inhibitor of cancer-associated mutant IDH1.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 34 publications
0
14
0
Order By: Relevance
“…The in‐house NPs database are a collection of fungal metabolites isolated by our group. Based on their structural novelty, the molecules in the database may have promising biological activities . Structure‐based virtual ligand screening facilitated the early stage small‐molecule inhibitor discovery.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The in‐house NPs database are a collection of fungal metabolites isolated by our group. Based on their structural novelty, the molecules in the database may have promising biological activities . Structure‐based virtual ligand screening facilitated the early stage small‐molecule inhibitor discovery.…”
Section: Resultsmentioning
confidence: 99%
“…In this work, we applied in silico screening techniques to identify PI3K α inhibitors from the in‐house NPs library, and wortmannolol ( 1 ) was identified as a promising candidate which showed significant PI3K α inhibitory activity in vitro and in vivo. Our work suggested, for the first time, that wortmannolol, as a PI3K α inhibitor, is selectively cytotoxic to cancer cells and has potential to become a novel agent for cancer therapy.…”
Section: Introductionmentioning
confidence: 99%
“…Isocitrate dehydrogenase 1 (IDH1) catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate (α-KG). Neomorphic mutations in IDH1, mostly occurring at arginine 132, are frequently found in several human cancer types, including glioma, acute myeloid leukemia (AML), and myeloproliferative neoplasm [ 17 ]. When our research group screened for the IDH1 inhibitors from our natural product libraries, all the isolates 1 – 5 were evaluated for IDH1 inhibitory activity; unfortunately, none of them was active at a concentration of 20 μM.…”
Section: Resultsmentioning
confidence: 99%
“…The theoretical calculations of compounds 1a / 1b and 2a / 2b were performed using Gaussian 09 and figured using GaussView 5.0 (He et al, 2017a , b , c ; Hu et al, 2017 ). Conformation search using molecular mechanics calculations was performed in the Discovery Studio 3.5 Client with MMFF force field with 20 kcal mol −1 upper energy limit (Smith and Goodman, 2010 ).…”
Section: Methodsmentioning
confidence: 99%